 |
|
Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
September 07, 2007A new study has found an unexpected number of viruses and viral subtypes in patients with respiratory tract infections (RTIs). The technique used in the study may help identify new viruses associated with human diseases. The study is published in the September 15 issue of The Journal of Infectious Diseases, now available online.
RTIs, such as the common cold, are associated with some of the most common viral infections, and increase the risk of an asthma attack in those with the condition. Fifty to 80 percent of asthma exacerbations are precipitated by viral upper RTIs, and yet these viruses are still poorly understood.
The Virochip technique, a DNA microarray or genome chip developed by researchers at the University of California, San Francisco, uses the most conserved sequences of all known viruses of humans, animals, plants, and microbes for its detection system. The new study is the first to employ this strategy to investigate the viruses associated with RTIs in people with and without asthma.
The study, conducted by Amy Kistler, PhD, and colleagues in California, Illinois, and Missouri, used several methods to test 53 asthmatic and 30 non-asthmatic adults for viruses at various stages of health. Compared to the conventional methods of viral culture and the highly sensitive polymerase chain reaction (PCR) method, the Virochip had excellent agreement in terms of identifying viral pathogens, and proved to be both highly sensitive and specific.
The method "detected remarkable and unanticipated diversity" of viruses linked with RTIs and identified "a wholly new branch of the phylogenetic tree," for the human rhinovirus, one of the causative agents of the common cold virus, Dr. Kistler notes, showing that even with a small test group the Virochip enabled detection of new viruses that were not possible to culture. The researchers also detected 30 distinct known species of rhinoviruses and found that only one of the two coronaviruses thought to be responsible for up to 15 percent of all colds in the United States was detectable in this study population. Instead, two newly described strains of coronaviruses dominated.
These findings are particularly important given the poor understanding of the role of viral diversity in RTIs and in asthma exacerbations. As a next step, Kistler suggested that future groups use the Virochip to continue to accumulate knowledge about such viruses. "The range and depth of viral detection [using the Virochip] is significant, since gaining a comprehensive understanding of the viral pathogen diversity associated with asthma exacerbations may enable the development of specific strategies for treating or preventing asthma exacerbations caused by viral respiratory infection."
In an accompanying editorial, James E. Gern, MD and William W. Busse, MD of the University of Wisconsin School of Medicine and Public Health agreed that the Virochip assay could prove an excellent new tool for future studies looking to detect and understand novel viruses associated with respiratory illnesses.
Infectious Diseases Society of America
The study, conducted by Amy Kistler, PhD, and colleagues in California, Illinois, and Missouri, used several methods to test 53 asthmatic and 30 non-asthmatic adults for viruses at various stages of health. Compared to the conventional methods of viral culture and the highly sensitive polymerase chain reaction (PCR) method, the Virochip had excellent agreement in terms of identifying viral pathogens, and proved to be both highly sensitive and specific.
The method "detected remarkable and unanticipated diversity" of viruses linked with RTIs and identified "a wholly new branch of the phylogenetic tree," for the human rhinovirus, one of the causative agents of the common cold virus, Dr. Kistler notes, showing that even with a small test group the Virochip enabled detection of new viruses that were not possible to culture. The researchers also detected 30 distinct known species of rhinoviruses and found that only one of the two coronaviruses thought to be responsible for up to 15 percent of all colds in the United States was detectable in this study population. Instead, two newly described strains of coronaviruses dominated.
These findings are particularly important given the poor understanding of the role of viral diversity in RTIs and in asthma exacerbations. As a next step, Kistler suggested that future groups use the Virochip to continue to accumulate knowledge about such viruses. "The range and depth of viral detection [using the Virochip] is significant, since gaining a comprehensive understanding of the viral pathogen diversity associated with asthma exacerbations may enable the development of specific strategies for treating or preventing asthma exacerbations caused by viral respiratory infection."
In an accompanying editorial, James E. Gern, MD and William W. Busse, MD of the University of Wisconsin School of Medicine and Public Health agreed that the Virochip assay could prove an excellent new tool for future studies looking to detect and understand novel viruses associated with respiratory illnesses.
Infectious Diseases Society of America
Respiratory Infection Current Events and Respiratory Infection News RSSCommon cold virus came from birds
A virus that causes cold-like symptoms in humans originated in birds and may have crossed the species barrier around 200 years ago, according to an article published in the December issue of the Journal of General Virology. Scientists hope their findings will help us understand how potentially deadly viruses emerge in humans.
A card-swipe for medical tests
University of Utah scientists successfully created a sensitive prototype device that could test for dozens or even hundreds of diseases simultaneously by acting like a credit card-swipe machine to scan a card loaded with microscopic blood, saliva or urine samples.
New TB test reveals patients at risk, says study
A recently introduced blood test can reveal which patients may develop active tuberculosis (TB) much more precisely than the 100-year old TB skin test, according to a new study published today in the journal Annals of Internal Medicine.
Preventing colds: Washing your hands is more effective than taking vitamins
The days are getting shorter, temperatures are dropping, and the cold and flu season is beginning. Many people have started taking vitamin C tablets as a precautionary measure. But research has shown that vitamin supplements do not provide nearly as much protection as other measures, like frequently washing your hands - and that high doses can even be harmful.
Substance found in fruits and vegetables reduces likelihood of the flu
Mice given quercetin, a naturally occurring substance found in fruits and vegetables, were less likely to contract the flu, according to a study published by The American Physiological Society. The study also found that stressful exercise increased the susceptibility of mice to the flu, but quercetin canceled out that negative effect.
Kids with pets grow up to be snorers
A predisposition to adult snoring can be established very early in life. Research published today in BioMed Central's open access journal Respiratory Research describes possible childhood risk factors, including exposure to animals, early respiratory or ear infections and growing up in a large family.
New agent strikes at respiratory syncytial virus replication
University of Texas Medical Branch at Galveston researchers have achieved promising results with a potential new weapon against respiratory syncytial virus, the most common cause of infant hospitalization in the United States.
Respiratory infections linked to increased heart attacks and strokes
A new study, which appears today in the online edition of the European Heart Journal, has found strong evidence that recent respiratory infections increase the risk of heart attacks and strokes, both of which are more common in the winter.
Blocking effects of viral infections may prevent asthma in young children
Babies who get severe respiratory viral infections are much more likely to suffer from asthma as they get older.
Fears about complications shouldn't drive antibiotic prescribing
Antibiotics are not justified to reduce the risk of complications after upper respiratory tract infection, sore throat, or ear infection, finds a study published on bmj.com today.
More Respiratory Infection Current Events and Respiratory Infection News Articles
 | Respiratory Infections by Michael S Niederman, George A Sarosi, Jeffrey L Glassroth This book, written by three recognized authorities in the field of respiratory infections, offers a state-of-the-art review of respiratory infections and emphasizes diagnostic techniques and new treatments for infectious diseases. The authors bring their expertise in pharmaceuticals and fungal infections to the forefront of this volume that has been written for physicians in pulmonary medicine,... |
 | Community-Acquired Respiratory Infections (Infectious Disease and Therapy) by Charles H. Nightingale, Paul G. Ambrose, Thomas M. File Jr. Access direct and focused answers to frequently asked questions regarding the management of commonly encountered infections of this kind. Committed to delivering adoptable recommendations and total coverage of the available clinical treatments, this text merges the medical with the pharmacodynamic and pharmacoeconomic - drug cost differentials, dosages and regimen planning guidelines - to offer a... |
 | Respiratory Tract Infection (Fast Facts) by Robert C. Read Second author, Donald E. Craven, is with Tufts Univ., Boston, MA. Quick reference covers newly described respiratory pathogens, emerging antibiotic resistance, difficulty in reaching a rapid diagnosis to guide treatment, and high morbidity and mortality associated with improper selection of therapy. Prev. ed: c1998.... |
| Bacterial Infections of the Respiratory Tract in Dogs and Cats by Lesley G. King | |
 | Management of Respiratory Tract Infections by John G Bartlett Now in its Third Edition, this handbook is a practical quick-reference guide for infectious disease physicians, primary care practitioners and other clinicians who treat upper and lower respiratory tract infections. This edition includes information on seven new drugs that have recently been approved or are awaiting approval. Also included are new guidelines from the Infectious Diseases Society... |
| Developments in Antibiotic Treatment of Respiratory Infections (New Perspectives in Clinical Microbiology) | |
| Visual Diagnosis Self-Tests in Respiratory Tract Infections (Visual Diagnosis Self-Tests) by Paul S. Thomas | |
 | The Microbe-Host Interface in Respiratory Tract Infections The molecular pathogenesis of microbial agents responsible for respiratory tract infections (RTIs) has been the focus of much research in recent years. The emphasis has been on developing new treatments such as novel antimicrobials and more effective vaccines. Significant attention has also been paid to improving molecular diagnostic methods to identify RTI-causing microbes, as well as... |
| Upper Respiratory and Head and Neck Infections (Atlas of Infectious Diseases, Vol 4) by Gerald L. Mandell Georgetown University, Washington, D.C. Color photographic atlas of the etiologies and manifestations of infections of the head, neck, and upper respiratory tract. For infectious disease physicians and pathologists. 14 U.S.... | |
 | Respiratory Infections (A Hodder Arnold Publication) by Antoni Torres, Santiago Ewig, Lionel Mandell, Mark Woodhead The aim of the volume is to provide an authoritative and international treatise bringing together current knowledge in the field of respiratory infection. The book will be organised by presentation rather than causative organism, a differentiating feature from the existing competition, and will be divided into four parts -- 'General Issues', 'Community-acquired Infections', 'Nosocomial... |
| © 2008 BrightSurf.com |